A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Clinical trial NCT06336148 · TERMINATED
Trial details
- NCT number
- NCT06336148
- Sponsor
- Actym Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-05
- Primary completion
- 2025-08-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.